Differential Prevalence of Depression Symptoms in Obese Versus Non-obese Women with Polycystic Ovary Syndrome
Investigating the Impact of Obesity on Depression in PCOS Patients
DOI:
https://doi.org/10.69750/dmls.01.03.033Keywords:
PCOS, obese, depression, prevalence, Treatment, Hyperandrogenism, Endocrine disorder, Beck Depression Inventory-IIAbstract
Background: Polycystic ovarian syndrome (PCOS) is a prevalent chronic endocrine disorder that effects on women ovaries. It is characterized by mental health issues including depression and obesity. Hence the purpose of this particular study was to determine whether depressive symptoms were more common in obese PCOS women or in non-obese women.
Methodology: The current study involved a cross-sectional design where the participants were 200 women with PCOS, and they were further divided into the obese and non-obese groups on the bases of their BMI. The depressive symptoms were assessed with the Beck Depression Inventory – II (BDI-II). Raw data were interpreted bio- statistically by applying chi-squared test and logistic regression to determine the association between symptoms of obesity and depression by using a software known as SPSS.
Results: The women of obese group with polycystic ovarian syndrome had a mean score of moderate (35.12± 0.01) and severe depressed symptoms than the non-obese PCOS women (22.11± 0.03). The applications of the logistic regression model revealed that the obesity could be considered to have a statistically significant (P≤0.05) impact on the depression symptoms.
Conclusion: Through the research that the study carried out it was discovered that obesity could be causatively related to depression in women with PCOS. These results point to the importance of the proposed features of PCOS as a complex disorder that requires a holistically oriented treatment approach that involves not only physical but also psychological factors.
Downloads
References
Rabiepoor S, Yas A. Quality of life in normal and overweight women with polycystic ovary syndrome: a cross-sectional study. J Midwifery Reprod Health. 2022;10(3).
Kara O, Kaymaz N, Uzun ME. Effect of hyperandrogenism and obesity on mindfulness and metacognition in adolescents with polycystic ovary syndrome. Arch Womens Ment Health. 2022;25(5):911-21.
Ali A, Guidozzi F. Midlife women’s health consequences associated with polycystic ovary syndrome. Climacteric. 2020;23(2):116-22.
Burgert TS, Paprocki E. Prevalence, presentation, and diagnosis of PCOS in adolescents. In: Pal L, Seifer DB, editors. Polycystic Ovary Syndrome. Cham: Springer; 2022. p.13-26.
Ressler IB, Grayson BE, Ulrich-Lai YM, Seeley RJ. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab. 2015;308(12):E1076-84.
Chu Y, Hilbert J, Mohsenin V. Obstructive sleep apnea and polycystic ovary syndrome. In: Pal L, Seifer DB, editors. Polycystic Ovary Syndrome. Cham: Springer; 2022. p.393-409.
Lüll K, Arffman RK, Sola-Leyva A, Molina NM, Aasmets O, Herzig KH, et al. The gut microbiome in polycystic ovary syndrome and its association with metabolic traits. J Clin Endocrinol Metab. 2021;106(3):858-71.
Pastore LM, Patrie JT, Morris WL, Dalal P, Bray MJ. Depression symptoms and body dissatisfaction in women with polycystic ovary syndrome. J Psychosom Res. 2011;71(4):270-6.
Jäger P, Wolicki A, Spohnholz J, Senkal M. Sex-specific aspects in bariatric treatment of severely obese women. Int J Environ Res Public Health. 2020;17(8):2734.
Franik G, Krysta K, Witkowska A, Dudek A, Krzystanek M, Madej P. Impact of sex hormones and metabolic markers on depressive symptoms and cognition in PCOS. Gynecol Endocrinol. 2019;35(11):965-9.
Cai M, Ni Z, Yao Y, Yu J, Yu C, Zhou L, et al. Characteristics of gut microbiota and its relationship with serum sex hormones in non-obese PCOS patients with insulin resistance. 2022.
Lüll K, Arffman RK, Sola-Leyva A, Molina NM, Aasmets O, Herzig KH, et al. Gut microbiome in polycystic ovary syndrome and metabolic traits. J Clin Endocrinol Metab. 2021;106(3):858-71.
Desai A, Madar IH, Asangani AH, Ssadh HA, Tayubi IA. Influence of PCOS in obese vs non-obese women: in silico biomarker discovery. Bioinformation. 2017;13(4):111-5.
Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E. Polycystic ovary syndrome and NC-CAH: systematic review. Front Endocrinol. 2019;10:388.
Ananya P, Shailesh N. Insulin resistance in polycystic ovarian syndrome. Cureus. 2022;14(10):e30351.
Wright PJ, Corbett CF, Dawson RM, Wirth MD, Pinto BM. Fitness assessments in women with PCOS: feasibility study. Clin Exp Obstet Gynecol. 2023;50(4).
Sruthi VL, Bindu PM, Sri Y. Prevalence of polycystic ovarian syndrome among medical students. Int J Acad Med Pharm. 2023;5(3):117-22.
Rhee SJ, Min S, Hong M, Lee H, Lee HS, Kang DH, et al. Association between insulin resistance and depressive symptoms: national cross-sectional study. J Psychosom Res. 2023;175:111502.
Joshi B, Patil A, Kokate PP, Akula AJ, Shaikh SA, Tandon D, et al. Quality of life using PCOSQ and coping mechanisms in PCOS. J Obstet Gynaecol India. 2023;73(2):172-9.
Turkmen S, Andreen L, Cengiz Y. Effects of Roux-en-Y surgery on eating behavior in obese PCOS women. Gynecol Endocrinol. 2015;31(4):301-5.
Wroolie TE, Kenna HA, Singh MK, Rasgon NL. Insulin resistance and cognition in depressive disorders: age-specific effects. J Psychiatr Res. 2015;60:65-72.
Downloads
Published
Issue
Section
License
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.














